1315478-16-0 Usage
General Description
2-Butyl-1,6-dihydro-4-methyl-6-oxo-5-Pyrimidineacetic acid is a chemical compound that falls into the category of pyrimidines and their derivatives, which are aromatic compounds containing one or more pyrimidine rings. It's characterized by its unique structure, featuring a 2-butyl group, which refers to a four-carbon chain attached at the second carbon, and a 1,6-dihydro-4-methyl-6-oxo component. This structure indicates that the compound potentially has multiple reactive sites, making it valuable in various chemical reactions. In addition, the terminal acetic acid group implies some degree of acidity, which could manipulate the compound's functional properties depending on the reaction conditions. Its exact uses or roles in industrial or scientific processes might be subject to further studies.
Check Digit Verification of cas no
The CAS Registry Mumber 1315478-16-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,5,4,7 and 8 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1315478-16:
(9*1)+(8*3)+(7*1)+(6*5)+(5*4)+(4*7)+(3*8)+(2*1)+(1*6)=150
150 % 10 = 0
So 1315478-16-0 is a valid CAS Registry Number.
1315478-16-0Relevant articles and documents
Method for preparing Fimasartan
-
Paragraph 0040; 0041, (2019/01/16)
The invention discloses a method for preparing Fimasartan. The method comprises the steps that valeronitrile is used as a raw material to prepare pentanimidamide hydrochloride, then pentanimidamide hydrochloride and acetylsuccinic acid diethyl ester conduct a cyclization reaction and an amidation reaction to prepare 2-(2-normal-butyl-4-hydroxyl-6-methylpyrimidine-5-radical)-N,N-dimethylacetamide (intermediate II), the intermediate II is subjected to sulfo-carbonylation through a Lawesson's reagent to obtain 2-(2-normal-butyl-4-hydroxyl-6-methylpyrimidine-5-radical)-N,N-dimethylacetamide (intermediate III), the intermediate III is subjected to an N-alkylation reaction, radicals are protected through detritylation, and Fimasartan is prepared. The preparation method has the advantages of highreaction selectivity, high synthesis yield, high reaction efficiency and the like.
